{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:59:23Z","timestamp":1790225963130,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00296-020-04661-x","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T20:03:35Z","timestamp":1596053015000},"page":"1657-1666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study with a clinical phenotype approach"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-4423","authenticated-orcid":false,"given":"Adri\u00e1n E.","family":"Caballero-Islas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0841-6695","authenticated-orcid":false,"given":"Irma","family":"Hoyo-Ulloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5021-6959","authenticated-orcid":false,"given":"Annette","family":"Garc\u00eda-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-3995","authenticated-orcid":false,"given":"Andrea","family":"Hinojosa-Azaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"4661_CR1","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","volume":"12","author":"D Cornec","year":"2016","unstructured":"Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U (2016) ANCA-associated vasculitis-clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol 12:570\u2013579","journal-title":"Nat Rev Rheumatol"},{"key":"4661_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/BOR.0b013e328346c332","volume":"23","author":"H Tadema","year":"2011","unstructured":"Tadema H, Heeringa P, Kallenberg CG (2011) Bacterial infections in Wegener's granulomatosis: mechanisms potentially involved in autoimmune pathogenesis. Curr Opin Rheumatol 23:366\u2013371","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 1","key":"4661_CR3","doi-asserted-by":"publisher","first-page":"i171","DOI":"10.1093\/ndt\/gfv045","volume":"30","author":"JG McGregor","year":"2015","unstructured":"McGregor JG, Negrete-Lopez R, Poulton CJ et al (2015) Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function. Nephrol Dial Transplant 30(Suppl 1):i171\u2013i181","journal-title":"Nephrol Dial Transplant"},{"key":"4661_CR4","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s10067-018-4067-5","volume":"37","author":"J Yoo","year":"2018","unstructured":"Yoo J, Jung SM, Song JJ, Park YP, Lee SW (2018) Birmingham vasculitis activity and chest manifestation at diagnosis can predict hospitalised infection in ANCA-associated vasculitis. Clin Rheumatol 37:2133\u20132141","journal-title":"Clin Rheumatol"},{"key":"4661_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrneph.2012.107","volume":"8","author":"N Wall","year":"2012","unstructured":"Wall N, Harper L (2012) Complications of long-term therapy for ANCA-associated systemic vasculitis. Nat Rev Nephrol 8:523\u2013532","journal-title":"Nat Rev Nephrol"},{"key":"4661_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann O, Berden A, de Groot K et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70:488\u2013494","journal-title":"Ann Rheum Dis"},{"key":"4661_CR7","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1002\/art.34562","volume":"64","author":"S Lionaki","year":"2012","unstructured":"Lionaki S, Blyth ER, Hogan SL et al (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 64:3452\u20133462","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"4661_CR8","doi-asserted-by":"publisher","first-page":"i14","DOI":"10.1093\/ndt\/gfv022","volume":"30","author":"RA Watts","year":"2015","unstructured":"Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Su\u00e1rez LF (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):i14\u201322","journal-title":"Nephrol Dial Transplant"},{"key":"4661_CR9","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/rheumatology\/kez148","volume":"58","author":"A Mahr","year":"2019","unstructured":"Mahr A, Specks U, Jayne D (2019) Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum. Rheumatology (Oxford) 58:1707\u20131709","journal-title":"Rheumatology (Oxford)"},{"key":"4661_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"4661_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33:1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"4661_CR12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","volume":"44","author":"JH Stone","year":"2001","unstructured":"Stone JH, Hoffman GS, Merkel PA et al (2001) A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44:912\u2013920","journal-title":"Arthritis Rheum"},{"key":"4661_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.2006.062711","volume":"66","author":"B Hellmich","year":"2007","unstructured":"Hellmich B, Flossmann O, Gross WL et al (2007) EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-asssociated vasculitis. Ann Rheum Dis 66:605\u2013617","journal-title":"Ann Rheum Dis"},{"key":"4661_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165\u2013228","journal-title":"Intensive Care Med"},{"key":"4661_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10067-019-04779-9","volume":"39","author":"M Lao","year":"2020","unstructured":"Lao M, Huang M, Li C et al (2020) Infectious profile in inpatients with ANCA-associated vasculitis: a single-center retrospective study from Southern China. Clin Rheumatol 39:499\u2013507","journal-title":"Clin Rheumatol"},{"key":"4661_CR16","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/ard.2009.109389","volume":"69","author":"MA Little","year":"2010","unstructured":"Little MA, Nightingale P, Verburgh CA et al (2010) Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69:1036\u20131043","journal-title":"Ann Rheum Dis"},{"key":"4661_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/eci.12410","volume":"45","author":"A Kronbichler","year":"2015","unstructured":"Kronbichler A, Jayne DR, Mayer G (2015) Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis. Eur J Clin Invest 45:346\u2013368","journal-title":"Eur J Clin Invest"},{"key":"4661_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1080\/14397595.2016.1226468","volume":"27","author":"K Watanabe-Imai","year":"2017","unstructured":"Watanabe-Imai K, Harigai M, Sada KE et al (2017) Clinical characteristics of and risk factors for serious infection in Japanese patients within six months of remission induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis registered in a nationwide, prospective, inception cohort study. Mod Rheumatol 27:646\u2013651","journal-title":"Mod Rheumatol"},{"key":"4661_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/rheumatology\/keh522","volume":"44","author":"L Harper","year":"2005","unstructured":"Harper L, Savage CO (2005) ANCA-associated renal vasculitis at the end of the twentieth century-a disease of older patients. Rheumatology (Oxford) 44:495\u2013501","journal-title":"Rheumatology (Oxford)"},{"key":"4661_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez575","author":"A Lafarge","year":"2019","unstructured":"Lafarge A, Joseph A, Pagnoux C et al (2019) Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Stugy Group. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/kez575","journal-title":"Rheumatology (Oxford)"},{"key":"4661_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/ard.2008.088302","volume":"68","author":"C Charlier","year":"2009","unstructured":"Charlier C, Henegar C, Launay O et al (2009) Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis 68:658\u2013663","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"4661_CR22","doi-asserted-by":"publisher","first-page":"e19173","DOI":"10.1097\/MD.0000000000019173","volume":"99","author":"D Waki","year":"2020","unstructured":"Waki D, Nishimura K, Tokumasu H et al (2020) Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a retrospective observational study. Medicine (Baltimore) 99(8):e19173. https:\/\/doi.org\/10.1097\/MD.0000000000019173","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4661_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12882-019-1226-0","volume":"20","author":"D Chanouzas","year":"2019","unstructured":"Chanouzas D, McGregor JA, Nightingale P et al (2019) Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated vascultis: a multi-center retrospective cohodrt study. BMC Nephrol 20(1):58","journal-title":"BMC Nephrol"},{"key":"4661_CR24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh M, Merkel PA, Peh CA et al (2020) Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Eng J Med 382:622\u2013631","journal-title":"N Eng J Med"},{"key":"4661_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.autrev.2008.07.020","volume":"8","author":"CG Kallenberg","year":"2008","unstructured":"Kallenberg CG, Tadema H (2008) Vascultitis and infections: contribution to the issue of autoimmunity reviews devoted to \u201cautoimmunity and infection\u201d. Autoimmun Rev 8:29\u201332","journal-title":"Autoimmun Rev"},{"key":"4661_CR26","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3899\/jrheum.131426","volume":"41","author":"QY Lai","year":"2014","unstructured":"Lai QY, Ma TT, Li ZY, Chang DY, Zhao MH, Chen M (2014) Predictors for mortality in patients with antineutrophil cytoplasmic autoantibody-assocaited vasculitis: a study of 398 Chinese patients. J Rheumatol 41:1849\u20131855","journal-title":"J Rheumatol"},{"key":"4661_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3899\/jrheum.190065","volume":"47","author":"E Garcia-Vives","year":"2020","unstructured":"Garcia-Vives E, Segarra-Medrano A, Martinez-Valle F, Agraz I, Solans-Laque R (2020) Prevalence and risk factors for major infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis: influence on the disease outcome. J Rheumatol 47:407\u2013414","journal-title":"J Rheumatol"},{"key":"4661_CR28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190373","author":"N Ono","year":"2019","unstructured":"Ono N, Inoue Y, Miyamura T et al (2019) The association of airway comorbidities with the clinical phenotypes and outcomes of ANCA-associated vasculitis patients. J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.190373","journal-title":"J Rheumatol"},{"key":"4661_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.autrev.2014.10.020","volume":"14","author":"KN Konstantinov","year":"2015","unstructured":"Konstantinov KN, Ulff-M\u00f8ller CJ, Tzamaloukas AH (2015) Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. Autoimmun Rev 14:201\u2013203","journal-title":"Autoimmun Rev"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04661-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04661-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04661-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:19:38Z","timestamp":1627514378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04661-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4661"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04661-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AECI, IHU, AGC and AHA declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}